| Catalog Number |
PR51146566 |
| CAS |
51146-56-6 |
| Description |
Dexibuprofen is an ibuprofen. It has a role as a non-narcotic analgesic and a non-steroidal anti-inflammatory drug. It is an enantiomer of a levibuprofen. |
| Synonyms |
(S)-Ibuprofen |
| IUPAC Name |
(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid |
| Molecular Weight |
206.28 |
| Molecular Formula |
C13H18O2 |
| InChI |
HEFNNWSXXWATRW-JTQLQIEISA-N |
| InChI Key |
InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1 |
| Associated Therapies |
Analgesia |
| Documentation/Certification |
GMP / DMF |
| Drug Categories |
Acids, Carbocyclic; Agents causing hyperkalemia; Agents that produce hypertension; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Inflammatory Agents, Non-Steroidal (Non-Selective); Antiinflammatory and Antirheumatic Products; Antiinflammatory and Antirheumatic Products, Non-Steroids; Cytochrome P-450 CYP2C19 Substrates; Cytochrome P-450 CYP2C8 Substrates; Cytochrome P-450 CYP2C9 Substrates; Cytochrome P-450 Substrates; Musculo-Skeletal System; Nephrotoxic agents; Non COX-2 selective NSAIDS; Phenylpropionates; Propionates; UGT1A1 Substrates; UGT1A3 substrates; UGT1A9 Substrates; UGT2B7 substrates |
| Drug Interactions |
Abacavir-Dexibuprofen may decrease the excretion rate of Abacavir which could result in a higher serum level.
Abatacept-The metabolism of Dexibuprofen can be increased when combined with Abatacept.
Abciximab-The risk or severity of bleeding can be increased when Dexibuprofen is combined with Abciximab.
Abiraterone-The metabolism of Dexibuprofen can be decreased when combined with Abiraterone.
Abrocitinib-The metabolism of Abrocitinib can be decreased when combined with Dexibuprofen. |
| Isomeric SMILES |
C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O |
| Type |
Small Molecule |
| Therapeutic Category |
Anti-Inflammatory Agents |
It should be noted that our service is only used for research, not for clinical use.
